Rainbow Childrens Medicare Share Price
Sector: Healthcare Facilities
You have to be logged in to add this to Watchlist.
Login or Register
1575.80 -1.20 (-0.08%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1523.5
Today’s High
1590.3
52 Week Low
1065.05
52 Week High
1685
1573.80 -4.70 (-0.30%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1521.1
Today’s High
1593
52 Week Low
1069
52 Week High
1688.8
Key Metrics
- Market Cap (In Cr) 16029.98
- Beta -
- Div. Yield (%) 0.19
- P/B 12.73
- TTM P/E 61.4
- Peg Ratio 0.99
- Sector P/E 30.23
- D/E 0.57
- Open Price 1555
- Prev Close 1577
Rainbow Childrens Medicare Analysis
Price Analysis
-
1 Week0.16%
-
3 Months31.39%
-
6 Month18.87%
-
YTD32.31%
-
1 Year41.77%
Risk Meter
- 34% Low risk
- 34% Moderate risk
- 34% Balanced Risk
- 34% High risk
- 34% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 1
- 1
- 1
- 1
- Buy
- 3
- 3
- 1
- 1
- Hold
- 1
- 1
- 2
- 2
- Sell
- 1
- 1
- 1
- 1
- Strong Sell
- 0
- 0
- 0
- 0
- Total
- 6
- 6
- 5
- 5
Rainbow Childrens Medicare News
Rainbow Children's Medicare IPO: GMP, share allotment, listing date details
1 min read . 02 May 2022Rainbow Children's Medicare IPO: GMP, subscription status on last day of issue
1 min read . 29 Apr 2022Rainbow Childrens Medicare Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 1296.9
- Selling/ General/ Admin Expenses Total
- 481.54
- Depreciation/ Amortization
- 112.08
- Other Operating Expenses Total
- 221.2
- Total Operating Expense
- 980.1
- Operating Income
- 316.8
- Net Income Before Taxes
- 294.81
- Net Income
- 217
- Diluted Normalized EPS
- 21.38
- Period
- 2024
- Total Assets
- 2170.4
- Total Liabilities
- 911.47
- Total Equity
- 1258.93
- Tangible Book Valueper Share Common Eq
- 123.03
- Period
- 2024
- Cashfrom Operating Activities
- 321.4
- Cashfrom Investing Activities
- -226.47
- Cashfrom Financing Activities
- -101.78
- Net Changein Cash
- -6.85
- Period
- 2023
- Total Revenue
- 1173.57
- Selling/ General/ Admin Expenses Total
- 593.42
- Depreciation/ Amortization
- 90.27
- Other Operating Expenses Total
- 1.08
- Total Operating Expense
- 867.25
- Operating Income
- 306.32
- Net Income Before Taxes
- 281.78
- Net Income
- 210.83
- Diluted Normalized EPS
- 21.11
- Period
- 2023
- Total Assets
- 1770.96
- Total Liabilities
- 711.05
- Total Equity
- 1059.91
- Tangible Book Valueper Share Common Eq
- 103.9
- Period
- 2023
- Cashfrom Operating Activities
- 327.23
- Cashfrom Investing Activities
- -465.2
- Cashfrom Financing Activities
- 143.4
- Net Changein Cash
- 5.43
- Period
- 2022
- Total Revenue
- 973.76
- Selling/ General/ Admin Expenses Total
- 450.98
- Depreciation/ Amortization
- 83.26
- Other Operating Expenses Total
- 0.8
- Total Operating Expense
- 746.57
- Operating Income
- 227.18
- Net Income Before Taxes
- 187.35
- Net Income
- 138.27
- Diluted Normalized EPS
- 14.45
- Period
- 2022
- Total Assets
- 1295.75
- Total Liabilities
- 692.94
- Total Equity
- 602.8
- Tangible Book Valueper Share Common Eq
- 63.5
- Period
- 2022
- Cashfrom Operating Activities
- 223.73
- Cashfrom Investing Activities
- -175.34
- Cashfrom Financing Activities
- -44.06
- Net Changein Cash
- 4.32
- Period
- 2021
- Total Revenue
- 650.05
- Selling/ General/ Admin Expenses Total
- 369.22
- Depreciation/ Amortization
- 73.34
- Other Operating Expenses Total
- 0.08
- Total Operating Expense
- 559.74
- Operating Income
- 90.31
- Net Income Before Taxes
- 55.7
- Net Income
- 40.02
- Diluted Normalized EPS
- 4.35
- Period
- 2021
- Total Assets
- 1081.27
- Total Liabilities
- 634.9
- Total Equity
- 446.36
- Tangible Book Valueper Share Common Eq
- 48.11
- Period
- 2021
- Cashfrom Operating Activities
- 142.71
- Cashfrom Investing Activities
- -82.88
- Cashfrom Financing Activities
- -60.87
- Net Changein Cash
- -1.04
- Period
- 2020
- Total Revenue
- 719.39
- Selling/ General/ Admin Expenses Total
- 401.36
- Depreciation/ Amortization
- 69.41
- Other Operating Expenses Total
- 0.82
- Total Operating Expense
- 591.76
- Operating Income
- 127.63
- Net Income Before Taxes
- 93.36
- Net Income
- 55.73
- Diluted Normalized EPS
- 6.06
- Period
- 2020
- Total Assets
- 1019.24
- Total Liabilities
- 613.83
- Total Equity
- 405.4
- Tangible Book Valueper Share Common Eq
- 43.57
- Period
- 2020
- Cashfrom Operating Activities
- 170.41
- Cashfrom Investing Activities
- -117.03
- Cashfrom Financing Activities
- -51.81
- Net Changein Cash
- 1.56
- Period
- 2019
- Total Revenue
- 542.79
- Selling/ General/ Admin Expenses Total
- 299.85
- Depreciation/ Amortization
- 60.32
- Other Operating Expenses Total
- 0.55
- Total Operating Expense
- 453.28
- Operating Income
- 89.51
- Net Income Before Taxes
- 57.53
- Net Income
- 44.59
- Diluted Normalized EPS
- 4.85
- Period
- 2019
- Total Assets
- 926.4
- Total Liabilities
- 554.24
- Total Equity
- 372.15
- Tangible Book Valueper Share Common Eq
- 39.81
- Period
- 2019
- Cashfrom Operating Activities
- 127.24
- Cashfrom Investing Activities
- -116.89
- Cashfrom Financing Activities
- -8.69
- Net Changein Cash
- 1.66
- Period
- 2024-09-30
- Total Revenue
- 417.46
- Selling/ General/ Admin Expenses Total
- 53.75
- Depreciation/ Amortization
- 34.9
- Other Operating Expenses Total
- 164.96
- Total Operating Expense
- 305.28
- Operating Income
- 112.18
- Net Income Before Taxes
- 105.35
- Net Income
- 78.87
- Diluted Normalized EPS
- 7.77
- Period
- 2024-09-30
- Total Assets
- 2261.93
- Total Liabilities
- 918.5
- Total Equity
- 1343.43
- Tangible Book Valueper Share Common Eq
- 131.21
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 192.81
- Cashfrom Investing Activities
- -114.26
- Cashfrom Financing Activities
- -73.33
- Net Changein Cash
- 5.22
- Period
- 2024-06-30
- Total Revenue
- 330.22
- Selling/ General/ Admin Expenses Total
- 49
- Depreciation/ Amortization
- 34.14
- Other Operating Expenses Total
- 145.02
- Total Operating Expense
- 270.64
- Operating Income
- 59.58
- Net Income Before Taxes
- 53.35
- Net Income
- 39.53
- Diluted Normalized EPS
- 3.89
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 341.1
- Selling/ General/ Admin Expenses Total
- 127.25
- Depreciation/ Amortization
- 32.3
- Other Operating Expenses Total
- 66.38
- Total Operating Expense
- 267.86
- Operating Income
- 73.24
- Net Income Before Taxes
- 69.17
- Net Income
- 50.97
- Diluted Normalized EPS
- 5.02
- Period
- 2024-03-31
- Total Assets
- 2170.4
- Total Liabilities
- 911.47
- Total Equity
- 1258.93
- Tangible Book Valueper Share Common Eq
- 123.03
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 321.4
- Cashfrom Investing Activities
- -226.47
- Cashfrom Financing Activities
- -101.78
- Net Changein Cash
- -6.85
- Period
- 2023-12-31
- Total Revenue
- 335.96
- Selling/ General/ Admin Expenses Total
- 120.64
- Depreciation/ Amortization
- 27.66
- Other Operating Expenses Total
- 54.55
- Total Operating Expense
- 245.54
- Operating Income
- 90.42
- Net Income Before Taxes
- 84.76
- Net Income
- 62.12
- Diluted Normalized EPS
- 6.12
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 332.68
- Selling/ General/ Admin Expenses Total
- 120.22
- Depreciation/ Amortization
- 26.8
- Other Operating Expenses Total
- 52.65
- Total Operating Expense
- 241.91
- Operating Income
- 90.76
- Net Income Before Taxes
- 85.25
- Net Income
- 62.91
- Diluted Normalized EPS
- 6.2
- Period
- 2023-09-30
- Total Assets
- 1897.54
- Total Liabilities
- 758.12
- Total Equity
- 1139.42
- Tangible Book Valueper Share Common Eq
- 111.71
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 151.66
- Cashfrom Investing Activities
- -91.87
- Cashfrom Financing Activities
- -63.85
- Net Changein Cash
- -4.06
- Period
- 2023-06-30
- Total Revenue
- 287.16
- Selling/ General/ Admin Expenses Total
- 113.44
- Depreciation/ Amortization
- 25.33
- Other Operating Expenses Total
- 47.63
- Total Operating Expense
- 224.79
- Operating Income
- 62.38
- Net Income Before Taxes
- 55.62
- Net Income
- 41
- Diluted Normalized EPS
- 4.04
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 316.97
- Selling/ General/ Admin Expenses Total
- 112.52
- Depreciation/ Amortization
- 22.73
- Other Operating Expenses Total
- 63.71
- Total Operating Expense
- 241.69
- Operating Income
- 75.28
- Net Income Before Taxes
- 70.1
- Net Income
- 53.6
- Diluted Normalized EPS
- 5.31
- Period
- 2023-03-31
- Total Assets
- 1770.96
- Total Liabilities
- 711.05
- Total Equity
- 1059.91
- Tangible Book Valueper Share Common Eq
- 103.9
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 327.23
- Cashfrom Investing Activities
- -465.2
- Cashfrom Financing Activities
- 143.4
- Net Changein Cash
- 5.43
- Period
- 2022-12-31
- Total Revenue
- 306.4
- Selling/ General/ Admin Expenses Total
- 112.1
- Depreciation/ Amortization
- 23.18
- Other Operating Expenses Total
- 47.31
- Total Operating Expense
- 222.83
- Operating Income
- 83.58
- Net Income Before Taxes
- 78.32
- Net Income
- 57.92
- Diluted Normalized EPS
- 5.74
- Period
- 2022-12-31
- Period
- 2022-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Rainbow Childrens Medicare Technical
Moving Average
SMA
- 5 Day1609.2
- 10 Day1591.36
- 20 Day1533.8
- 50 Day1439.14
- 100 Day1330.09
- 300 Day1308.4
Rainbow Childrens Medicare Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Krishna Instit Of Medical Scienc
- 582.4
- 15.45
- 2.73
- 603.95
- 350.02
- 4660.83
- Aster DM Healthcare
- 426.55
- -6.95
- -1.6
- 464
- 252.99
- 21232.51
- Rainbow Childrens Medicare
- 1575.8
- -1.2
- -0.08
- 1685
- 1065.05
- 15994.69
- Vijaya Diagnostic Centre
- 1130.5
- 62.2
- 5.82
- 1136
- 580.75
- 11570.18
- Metropolis Healthcare
- 2012.05
- -4.9
- -0.24
- 2306.85
- 1450.05
- 10307.49
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Krishna Instit Of Medical Scienc
- 73.24
- 12.41
- 22.79
- 15.53
- Aster DM Healthcare
- 176.19
- 4.73
- 6.24
- 4.26
- Rainbow Childrens Medicare
- 74.05
- 12.73
- 19.88
- 13.8
- Vijaya Diagnostic Centre
- 92.15
- 16.64
- 22.14
- 21.2
- Metropolis Healthcare
- 81.25
- 9.44
- 20.59
- 14.66
Rainbow Childrens Medicare Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 27-Oct-24
- Quarterly Results
- 13-Aug-24
- Quarterly Results
- 19-May-24
- Audited Results & Final Dividend
- 24-Jan-24
- Quarterly Results
- 30-Oct-23
- Quarterly Results
- 07-Aug-23
- Quarterly Results
- 14-May-23
- Audited Results & Final Dividend
- 09-Feb-23
- Quarterly Results
- 03-Nov-22
- Quarterly Results
- 08-Aug-22
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 30-Jul-24
- 21-May-24
- AGM
- 19-Mar-24
- 15-Feb-24
- POM
- 27-Dec-23
- 23-Nov-23
- POM
- 29-Jun-23
- 14-May-23
- AGM
- 09-May-23
- 06-Apr-23
- POM
- 15-Sept-22
- 08-Aug-22
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 21-May-24
- 23-Jul-24
- 23-Jul-24
- 3
- 15-May-23
- 22-Jun-23
- 22-Jun-23
- 3